Log-rank test results show significant differences between the intermediate PLCβ1 group and the PLCβ1 downregulated groups for glioma (p = 3.0E-09) and its subclass astrocytoma (p = 2.0E-04) in a Kaplan-Meier survival plot. Here, PLCB1 is linked to central nervous system cancer.